Koninklijke Philips stock
Price history
+13.27% over the period1 year: from €24.34 (November 17, 2025) to €27.57 (November 16, 2026), +13.27%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 16, 2026 | €27.57 |
| October 30, 2026 | €24.24 |
| September 30, 2026 | €21.62 |
| August 31, 2026 | €22.91 |
| July 31, 2026 | €22.74 |
| June 30, 2026 | €23.76 |
| May 29, 2026 | €22.87 |
| April 30, 2026 | €22.39 |
| March 31, 2026 | €23.34 |
| February 27, 2026 | €27.08 |
| January 30, 2026 | €24.13 |
| December 31, 2025 | €23.24 |
| November 28, 2025 | €24.26 |
| November 17, 2025 | €24.34 |
At a glance
The company
Health technology company providing diagnostic imaging, therapy systems, monitoring solutions and personal health products
Latest results
Quarter to September 30, 2026 · EPS €0.40 (estimate €0.34)
TickerLandia's take on Koninklijke Philips
- Cheaper than usual relative to earnings: P/E on the latest fiscal year 30 vs a median of 36 over its last 7 fiscal years.
- Pricier than similar companies: trailing 12-month P/E 67 vs 31 (+115%) in a group of 10.
- Strong point: Market momentum (74/100 in its group). Weak point: Growth (13/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−1.75% from the 52-week high
Analysts · 20 analysts
Average target€28.03+1.76% vs. price
Buy 8 · Hold 12 · Sell 0 · Buy
TickerLandia Fingerprint: Koninklijke Philips
Compared with similar companies: very low growth, very low profitability, and very low earnings stability.
Financials and price compared with 31 companies in the medical devices industry, worldwide. Momentum and risk compared with 1,160 European stocks.
Pricelow35
How much it costs relative to what it produces.
Metric Value Position in group Forward P/E 15.7 25 P/E (trailing 12 months) 66.9 84 EV/EBITDA 14.6 42 Price/sales 1.51 8 Price/book 2.32 15 Profitabilityvery low15
How much it earns on revenue and capital.
Metric Value Position in group Gross margin 46.4% 24 Net margin 5.4% 11 ROE 8.6% 21 Operating margin 8.8% 5 ROA 3.6% 11 Earnings stabilityvery low16
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 3.4% 27 Loss-making yearscounts in reverse: lower means more earnings stability 3 of 5 annual reports 5 Growthvery low13
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +0.01% 15 Revenue growth (year over year) +2.10% 18 Earnings growth (year over year) −85.40% 8 Financial strengthvery low19
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength 2.60 16 Interest coverage 5.28 12 Debt/equitycounts in reverse: lower means more financial strength 0.70 24 Current ratio 1.33 24 Dividendhigh63
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years 2 years 12 Dividend yield 3.1% 88 Payout ratiopays out more than its earnings 207.3% 89 Market momentumstrong74
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +13.62% 87 Relative strength (6 months) +11.09% 77 1-year return +9.59% 48 Distance from 200-day average +16.02% 82 Riskaverage43
How much the price swings.
Metric Value Position in group Volatility (60 days) 22.9% 32 Beta (1 year) 0.76 51 Maximum drawdown (12 months) 23.3% 46
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Koninklijke Philips is cheaper than in the past and pricier than similar companies
On the latest fiscal year's earnings (2025), Koninklijke Philips's P/E today is 29.6, below the median of its last 7 fiscal years (35.8; between 21.6 and 47.8 from 2016 to 2025). Koninklijke Philips's P/E (trailing 12 months): 66.9, +115% against the median of a group of 10 similar companies (31.1).
Compared with 10 similar companies
| Metric | Koninklijke Philips | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 66.9 | High | |
| Forward P/E | 15.7 | Low | |
| Operating margin | 8.8% | Low | |
| ROE | 8.6% | Low | |
| Debt/equity | 0.70 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Koninklijke Philips. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
€4.39B
Latest quarter · Q3 2026
Net income
€27M
Latest quarter · Q3 2026
Quarterly net margin
0.6%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- €26.82B
- P/E
- 66.9
- EPS
- €0.41
- Volume
- 2.15M
- Daily trading
- €60.44M
- Dividend yield
- 3.09%
- Last ex-dividend on May 12, 2026
How Koninklijke Philips is changing
All resultsRevenue grew 0.6% a year on average over the last 5 years
Operating margin rose from −1.0% to 8.0%
Profitable in 2 of 5 fiscal years
Returns
Koninklijke Philips returns with dividends
€1,000 invested in Koninklijke Philips 5 years ago, on November 16, 2021, would be worth €904 today with dividends reinvested: −9.60% in total, −2.00% per year. On price alone it would be €808 (−19.25%).
| Period | Koninklijke Philips | AEX | €1,000 becomes |
|---|---|---|---|
| 1 month | +19.04% | −0.74% | €1,190 |
| 6 months | +26.10% | +12.92% | €1,261 |
| Year to date | +18.63% | +19.25% | €1,186 |
| 1 year | +17.62% | +20.00% | €1,176 |
| 3 years | +59.31% | +50.47% | €1,593 |
| 5 years | −9.60% | +37.26% | €904 |
| 10 years | +38.44% | +152.28% | €1,384 |
Over the last 6 months it has done better than 42% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. AEX: price only. Calculate your investment
The chart in detail
Koninklijke Philips: technical analysis
Koninklijke Philips shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 47.0% below its all-time closing high (€51.94, September 4, 2000).
- Trend
- No clear trend
- RSI (14 sessions)
- 82
- Above 70: a strong rise in a short time
- vs 200-session average
- +16.41%
Active signals
RSI above 70: the stock has risen a lot in a short time.
since October 28, 2026
Support and resistance
Price areas where Koninklijke Philips has stopped several times in the last year. They describe the chart; they are not forecasts.
- No resistance above: the price is near the highs of the year
- Last price€27.54
- Support€24.04−12.71%5 touches, last on August 14, 2026
- Support€22.97−16.61%2 touches, last on July 15, 2026
- Support€22.19−19.44%3 touches, last on September 28, 2026
Volatility and risk
Over the last year it has moved less than the AEX.
- Beta (1 year) vs AEX
- 0.75
- Volatility (60 sessions, annualised)
- 22.9%
- Largest fall in the last year
- −23.32%
Close of November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Koninklijke Philips: seasonality
Average monthly price change over 32 years
Over the last 32 years, the strongest month for Koninklijke Philips has been August: +7.00% on average, positive in 17 years out of 32. The weakest has been September: −2.14% on average, positive in 15 years out of 32. November, the current month, has been positive in 23 years out of 31 (+3.72% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +3.08% | +3.83% | 21 of 31 |
| February | +0.77% | −0.76% | 13 of 31 |
| March | −0.83% | −1.16% | 14 of 31 |
| April | +4.07% | +2.97% | 17 of 32 |
| May | −1.00% | −1.34% | 13 of 32 |
| June | −0.45% | −0.37% | 14 of 32 |
| July | +3.65% | +2.55% | 17 of 32 |
| August | +7.00% | +0.43% | 17 of 32 |
| September | −2.14% | −0.79% | 15 of 32 |
| October | −0.86% | −0.95% | 15 of 32 |
| November | +3.72% | +4.18% | 23 of 31 |
| December | +1.37% | +1.14% | 20 of 31 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Koninklijke Philips and its competitors
Diagnostic imaging is the core of Philips' business, covering magnetic resonance imaging, computed tomography, ultrasound and diagnostic X-ray, and it sits within the Diagnosis & Treatment segment alongside image guided therapy systems and devices. The Connected Care segment provides patient monitoring, enterprise informatics and sleep and respiratory care, while the Personal Health segment covers personal health products. The group sells in North America, Greater China and other international markets.
- Headquarters
- Amsterdam, Netherlands
- Employees
- 63,909
- Founded
- 1891
- Chief executive
- Roy Willem Jakobs
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Koninklijke PhilipsPHIA | $29.64B | 8.8% | 66.9 | +26.10% |
| Sonova HoldingSOON | $20.24B | 19.5% | 31.7 | +61.25% |
| Siemens HealthineersSHL | $54.36B | 13.5% | 22.3 | +31.74% |
| Smith & NephewSN. | $13.03B | 14.2% | 21.4 | +5.76% |
| DemantDEMANT | $10.92B | 17.2% | 30.5 | +48.01% |
| GetingeGETI.B | $7.63B | 14.3% | 27.1 | +49.29% |
Same industry or related industries, similar size. Compare Koninklijke Philips with its competitors · Full profile
